2[1]Textor SC.Atherosclerotic renovascular disease as a cause of end-stage renal disease:Cost considerations[J].Blood Purif,1996,14:305-314.
3[2]Leertouwer TC,Gussenhoven EJ,Bosch JL,et al.Stent placement for renal arterial stenosis:where do we stand? a Meta-analysis[J].Radiology,2000,216:78-85.
4[3]Zalunardo N,Tuttle KR.Atherosclerotic renal artery stenosis:current status and future directions[J].Curr Opin Nephrol Hypertens,2004,13:613-621.
5[4]Olin JW.Atherosclerotic renovascular disease:diagnosis and management[J].Curr Opin Cardiol,1990,5:659-665.
6[5]Rees CR.Stents for atherosclerotic renovascular disease[J].J Vasc Interv Radiol,1999,10:689-705.
7[6]Rundback JH,Sacks D,Kent KC,et al.Guidelines for the reporting of renal artery revascularization in clinical trials[J].Circulation,2002,106:1572-1585.
8[7]Beutler JJ,Van Ampting J MA,Van DE PGJ,et al.Longterm effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency[J].J Am Soc Nephrol,2001,12:1475-1481.
9[8]Morganti A,Bencini C,Vecchio CD,et al.Treatment of atherosclerotic renal artery stenosis[J].J Am Soc Nephrol,2003,13:S187-189.
10[9]United States Renal Data System (USRDS) 1997 Annual Data Report[C].Bethesda,Maryland,US Department of Health and Human Services/National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases,1997.
